Histogen HSTO
$ 0.66
31.6%
Quarterly report 2023-Q3
added 11-09-2023
Country |
USA |
IPO year |
2013 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Mr. Richard W. Pascoe |
Employees in the company |
22 |
Shares |
3.21 M |
Market Cap[1] |
$ 2.12 M |
EBITDA (LTM) |
$ -10.9 M |
P/E (LTM) |
-0.21 |
P/S (LTM) |
105.97 |
EPS (LTM) |
-3.21 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.